Bruker Corp (BRKR)
70.67
+0.23
(+0.33%)
USD |
NASDAQ |
Sep 27, 16:00
70.73
+0.06
(+0.08%)
After-Hours: 20:00
Bruker SG&A Expense (Annual): 730.10M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 730.10M |
December 31, 2022 | 610.80M |
December 31, 2021 | 564.50M |
December 31, 2020 | 477.80M |
December 31, 2019 | 504.80M |
December 31, 2018 | 453.10M |
December 31, 2017 | 420.20M |
December 31, 2016 | 394.40M |
December 31, 2015 | 402.80M |
December 31, 2014 | 454.20M |
December 31, 2013 | 444.00M |
December 31, 2012 | 440.40M |
December 31, 2011 | 410.90M |
Date | Value |
---|---|
December 31, 2010 | 301.10M |
December 31, 2009 | 254.00M |
December 31, 2008 | 254.50M |
December 31, 2007 | 219.70M |
December 31, 2006 | 112.99M |
December 31, 2005 | 96.06M |
December 31, 2004 | 95.90M |
December 31, 2003 | 77.76M |
December 31, 2002 | 63.42M |
December 31, 2001 | 49.81M |
December 31, 2000 | 20.25M |
December 31, 1999 | 14.76M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
477.80M
Minimum
2020
730.10M
Maximum
2023
577.60M
Average
564.50M
Median
2021
SG&A Expense (Annual) Benchmarks
Bio-Rad Laboratories Inc | 841.72M |
Azenta Inc | 316.28M |
Harvard Bioscience Inc | 46.89M |
Bionano Genomics Inc | 93.50M |
Akoya Biosciences Inc | 82.38M |